After taking a $245 million hit from the levies in 2025, CFO James Saccaro said the company plans more actions to mitigate ...

The 510(k) decision clears the device for use with ultra-rapid-acting insulins from Eli Lilly and Novo Nordisk.

Spending on the tests, which analyze genetic material from both people and pathogens, rose 20% year over year in 2024, the ...

The full financial impact of the price hikes could exceed $67 million each year in two dozen markets, according to the new ...

Johnson & Johnson’s Abiomed has sent an urgent medical device correction about a malfunction risk linked to 22 reports of ...

Pulsed field ablation has fueled strong sales growth for the firm’s electrophysiology business over the past two years.

The purchase will give Medtronic a larger presence in the cath lab, with a tool to help diagnose and treat coronary artery ...

Amid the upheaval, Grail continued to run studies to assess the ability of its Galleri blood test to detect a range of ...

The letter, which the FDA has not yet published, does not affect Beta Bionics’ ability to market, manufacture or distribute ...

Stryker expects the robot, called Mako RPS, to bring in new customers, including more ambulatory surgery centers.

Abbott needs to conduct more performance testing to ensure its FreeStyle Libre devices are accurate, FDA inspectors found.

From M&A to surgical robotics and user fee negotiations, the medical device industry has a busy year ahead. Check out MedTech ...